Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Bruker (BRKR) Long-Term Investments (2023 - 2024)

Historic Long-Term Investments for Bruker (BRKR) over the last 3 years, with Q4 2024 value amounting to $113.6 million.

Bruker's Long-Term Investments rose 4024.69% to $113.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $113.6 million, marking a year-over-year increase of 4024.69%. This contributed to the annual value of $113.6 million for FY2024, which is 4024.69% up from last year.
Per Bruker's latest filing, its Long-Term Investments stood at $113.6 million for Q4 2024, which was up 4024.69% from $81.0 million recorded in Q4 2023.
Over the past 5 years, Bruker's Long-Term Investments peaked at $113.6 million during Q4 2024, and registered a low of $81.0 million during Q4 2023.